Health news and commentary gathered by MedPage Today staff
— Health news and commentary gathered by MedPage Today staff
July 15, 2026
• 2 min read
Note that some links may require registration or subscription.
A preprint study flagged signals of frailty in seniors taking the GLP-1 drug tirzepatide (Zepbound) for weight loss. (Reuters via Yahoo!)
Approved 20 years ago as a diabetes treatment, GLP-1 drugs have been found to help patients reduce weight, changing the lives of…
Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.
Health news and commentary gathered by MedPage Today staff
Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of acute…
News and commentary from the endocrinology world
Kailera's GLP-1 pill data raises concerns, FDA clears Vera autoimmune therapy, and more biotech news from The Readout
